209 related articles for article (PubMed ID: 37773107)
1. PLCD3 promotes malignant cell behaviors in esophageal squamous cell carcinoma via the PI3K/AKT/P21 signaling.
Wang M; Gao M; Chen Y; Wu J; Wang X; Shu Y
BMC Cancer; 2023 Sep; 23(1):921. PubMed ID: 37773107
[TBL] [Abstract][Full Text] [Related]
2. Hsa_circ_0023984 Regulates Cell Proliferation, Migration, and Invasion in Esophageal Squamous Cancer via Regulating miR-1294/PI3K/Akt/c-Myc Pathway.
Liang W; Wang C; Wang J; Zhang M
Appl Biochem Biotechnol; 2022 Sep; 194(9):1-16. PubMed ID: 35522362
[TBL] [Abstract][Full Text] [Related]
3. Epiplakin1 promotes the progression of esophageal squamous cell carcinoma by activating the PI3K-AKT signaling pathway.
Qiao Z; Dai C; Wang Z; Wang Z; Wang Z; Zhang T; Niu W; Ma X
Thorac Cancer; 2022 Apr; 13(8):1117-1125. PubMed ID: 35238170
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of AKT by lysyl oxidase-like 2 activates the PI3K/AKT signaling pathway to promote proliferation, invasion and metastasis in esophageal squamous carcinoma.
Fan Z; Liu Y; Liu X; Nian W; Huang X; Yang Q; Hou S; Chen F
Clin Transl Oncol; 2023 Aug; 25(8):2487-2498. PubMed ID: 36995521
[TBL] [Abstract][Full Text] [Related]
5. PHLDA3 activated by BARX2 transcription, suppresses the malignant development of esophageal squamous cell carcinoma by downregulating PI3K/AKT levels.
Chen S; Lin X; He R; Zhang W; Kang M; Xu R
Exp Cell Res; 2023 May; 426(2):113567. PubMed ID: 36965748
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of DEAD-box 51 inhibits tumor growth of esophageal squamous cell carcinoma
Hu DX; Sun QF; Xu L; Lu HD; Zhang F; Li ZM; Zhang MY
World J Gastroenterol; 2022 Jan; 28(4):464-478. PubMed ID: 35125830
[TBL] [Abstract][Full Text] [Related]
7. HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway.
Wang H; Yang X; Guo Y; Shui L; Li S; Bai Y; Liu Y; Zeng M; Xia J
J Exp Clin Cancer Res; 2019 Jul; 38(1):324. PubMed ID: 31331361
[TBL] [Abstract][Full Text] [Related]
8. NEFL promotes invasion and migration of esophageal squamous carcinoma cells via the EGFR/AKT/S6 pathway.
Fan ZL; Yang LY; Zhang N; Feng D; Guo J; Chang C; Yuan Q; Cai Y; Zhang Y; Wei WQ; Wang MR; Hao JJ
Yi Chuan; 2022 Apr; 44(4):322-334. PubMed ID: 35437240
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of fibulin-4 inhibits autophagy and promotes the sensitivity of esophageal squamous cell carcinoma cells to apatinib by activating the Akt-mTOR signaling pathway.
Chen X; Wang J; Song L; Yu Y; Shi M; Jiang W; Liu X; He X
Thorac Cancer; 2022 Sep; 13(18):2592-2605. PubMed ID: 35950373
[TBL] [Abstract][Full Text] [Related]
10. Omipalisib Inhibits Esophageal Squamous Cell Carcinoma Growth Through Inactivation of Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) and ERK Signaling.
Zhu DS; Dong JY; Xu YY; Zhang XT; Fu SB; Liu W
Med Sci Monit; 2020 Aug; 26():e927106. PubMed ID: 32804918
[TBL] [Abstract][Full Text] [Related]
11. MiR-214 promotes cell meastasis and inhibites apoptosis of esophageal squamous cell carcinoma via PI3K/AKT/mTOR signaling pathway.
Guanen Q; Junjie S; Baolin W; Chaoyang W; Yajuan Y; Jing L; Junpeng L; Gaili N; Zhongping W; Jun W
Biomed Pharmacother; 2018 Sep; 105():350-361. PubMed ID: 29864623
[TBL] [Abstract][Full Text] [Related]
12. Significance of PI3K/AKT signaling pathway in metastasis of esophageal squamous cell carcinoma and its potential as a target for anti-metastasis therapy.
Li B; Xu WW; Lam AKY; Wang Y; Hu HF; Guan XY; Qin YR; Saremi N; Tsao SW; He QY; Cheung ALM
Oncotarget; 2017 Jun; 8(24):38755-38766. PubMed ID: 28418888
[TBL] [Abstract][Full Text] [Related]
13. LncRNA HCP5 promotes malignant cell behaviors in esophageal squamous cell carcinoma via the PI3K/AKT/mTOR signaling.
Xu J; Ma J; Guan B; Li J; Wang Y; Hu S
Cell Cycle; 2021 Jul; 20(14):1374-1388. PubMed ID: 34190001
[TBL] [Abstract][Full Text] [Related]
14. CircPDE5A-encoded novel regulator of the PI3K/AKT pathway inhibits esophageal squamous cell carcinoma progression by promoting USP14-mediated de-ubiquitination of PIK3IP1.
Lei K; Liang R; Liang J; Lu N; Huang J; Xu K; Tan B; Wang K; Liang Y; Wang W; Lin H; Wang M
J Exp Clin Cancer Res; 2024 Apr; 43(1):124. PubMed ID: 38658954
[TBL] [Abstract][Full Text] [Related]
15. [Chidamide inhibits proliferation and promotes apoptosis of esophageal squamous cell carcinoma cells by inhibiting the PI3K/Akt and ERK1/2 pathways and increasing DNA damage].
Gao M; Zhao B; Yang W; Tang J; Liu Y
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Nov; 43(11):1926-1934. PubMed ID: 38081611
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of Rictor enhances cell sensitivity to PI3K inhibitor LY294002 by blocking mTORC2-medicated phosphorylation of Akt/PRAS40 in esophageal squamous cell carcinoma.
Hou G; Zhao Q; Zhang M; Fan T; Liu M; Shi X; Ren Y; Wang Y; Zhou J; Lu Z
Biomed Pharmacother; 2018 Oct; 106():1348-1356. PubMed ID: 30119206
[TBL] [Abstract][Full Text] [Related]
17. [Effects of propranolol on biological function of human esophageal squamous cell carcinoma cells].
Zhuo QY; Qian H; Zhao BS; Qi B; Liu YZ
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2022 Nov; 38(6):754-759. PubMed ID: 37308430
[No Abstract] [Full Text] [Related]
18. E2F1-activated NRSN2 promotes esophageal squamous cell carcinoma progression through AKT/mTOR pathway.
Yan Z; Xu T; Lu J; Wu Z; Li X; Xu J; Guo W; Dong Z
Pathol Res Pract; 2022 Aug; 236():153963. PubMed ID: 35662041
[TBL] [Abstract][Full Text] [Related]
19. RUNX2 Plays An Oncogenic Role in Esophageal Carcinoma by Activating the PI3K/AKT and ERK Signaling Pathways.
Lu H; Jiang T; Ren K; Li ZL; Ren J; Wu G; Han X
Cell Physiol Biochem; 2018; 49(1):217-225. PubMed ID: 30138923
[TBL] [Abstract][Full Text] [Related]
20. Id-1 promotes tumorigenicity and metastasis of human esophageal cancer cells through activation of PI3K/AKT signaling pathway.
Li B; Tsao SW; Li YY; Wang X; Ling MT; Wong YC; He QY; Cheung AL
Int J Cancer; 2009 Dec; 125(11):2576-85. PubMed ID: 19551863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
